AllAfrica on MSN
Encouraging Results From a First-in-Human Phase 1 Clinical Trial of IAVI's Lassa Vaccine Candidate Published in New England Journal of Medicine
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways: IAVI's Lassa vaccine candidate rVSVΔG-LASV-GPC has an acceptable safety profile and ...
Genea Fertility, Australia's pioneering fertility network, is pleased to announce the appointment of internationally ...
Last year only 40% of the nine million people under 65 in a clinical risk group received the flu vaccine, leaving more than ...
Blue Fin Vision wins 2025 Health Care Award, reinforcing its status as a UK leader in precision eye surgery and transparent, ...
Trinity researchers, along with UK collaborators, have created a simple but powerful diagnostic tool, which they believe will ...
News-Medical.Net on MSN
Radiotherapy may be unnecessary for many breast cancer patients after mastectomy
Radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking ...
A Malaysian-born academic has made history with his appointment as the United Kingdom's first Chief Medical and Scientific ...
Like the astronomical explosion that kickstarted the universe, bowel cancer has a "Big Bang" moment which determines how it ...
People who need to lose weight quickly to access surgery will be given access to weight-loss drugs on the NHS in Wales.
TheHealthSite on MSN
LED Face Masks Advertisement Banned In UK After Shocking Misleading Claims About Acne And Rosacea, Here's Everything You Need To Know
The US health agencies, NIH, claim that acne vulgaris, herpes simplex and zoster and acute wound healing received a grade of ...
A United Kingdom-based non-governmental organisation, NaijAid UK, operating locally as HealthAidNG, has called for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback